HERBALIFE LTD (HLF) Stock Fundamental Analysis

NYSE:HLF • KYG4412G1010

19.26 USD
-0.34 (-1.73%)
Last: Feb 25, 2026, 12:27 PM
Fundamental Rating

4

Taking everything into account, HLF scores 4 out of 10 in our fundamental rating. HLF was compared to 36 industry peers in the Personal Care Products industry. HLF has a medium profitability rating, but doesn't score so well on its financial health evaluation. HLF may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year HLF was profitable.
  • HLF had a positive operating cash flow in the past year.
  • Each year in the past 5 years HLF has been profitable.
  • In the past 5 years HLF always reported a positive cash flow from operatings.
HLF Yearly Net Income VS EBIT VS OCF VS FCFHLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.19%, HLF is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA 8.19%
ROE N/A
ROIC N/A
ROA(3y)7.53%
ROA(5y)10.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HLF Yearly ROA, ROE, ROICHLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • The Profit Margin of HLF (4.53%) is better than 66.67% of its industry peers.
  • HLF's Profit Margin has declined in the last couple of years.
  • HLF's Operating Margin has declined in the last couple of years.
  • HLF has a Gross Margin of 77.87%. This is amongst the best in the industry. HLF outperforms 88.89% of its industry peers.
  • In the last couple of years the Gross Margin of HLF has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 4.53%
GM 77.87%
OM growth 3Y-3.15%
OM growth 5Y-3.06%
PM growth 3Y-9.79%
PM growth 5Y-7.59%
GM growth 3Y0.18%
GM growth 5Y-0.35%
HLF Yearly Profit, Operating, Gross MarginsHLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

2

2. Health

2.1 Basic Checks

  • HLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HLF has more shares outstanding
  • Compared to 5 years ago, HLF has less shares outstanding
  • The debt/assets ratio for HLF has been reduced compared to a year ago.
HLF Yearly Shares OutstandingHLF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HLF Yearly Total Debt VS Total AssetsHLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 1.22, we must say that HLF is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.22, HLF is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • HLF has a debt to FCF ratio of 7.88. This is a slightly negative value and a sign of low solvency as HLF would need 7.88 years to pay back of all of its debts.
  • The Debt to FCF ratio of HLF (7.88) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.88
Altman-Z 1.22
ROIC/WACCN/A
WACC9.28%
HLF Yearly LT Debt VS Equity VS FCFHLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • HLF has a Current Ratio of 1.13. This is a normal value and indicates that HLF is financially healthy and should not expect problems in meeting its short term obligations.
  • HLF has a worse Current ratio (1.13) than 75.00% of its industry peers.
  • HLF has a Quick Ratio of 1.13. This is a bad value and indicates that HLF is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HLF has a Quick ratio of 0.62. This is in the lower half of the industry: HLF underperforms 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
HLF Yearly Current Assets VS Current LiabilitesHLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. Growth

3.1 Past

  • HLF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.67%, which is quite good.
  • The earnings per share for HLF have been decreasing by -10.16% on average. This is quite bad
  • Looking at the last year, HLF shows a small growth in Revenue. The Revenue has grown by 0.89% in the last year.
  • HLF shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.89% yearly.
EPS 1Y (TTM)8.67%
EPS 3Y-14.35%
EPS 5Y-10.16%
EPS Q2Q%25%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-1.08%
Revenue growth 5Y-1.89%
Sales Q2Q%6.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.70% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, HLF will show a small growth in Revenue. The Revenue will grow by 3.55% on average per year.
EPS Next Y24.17%
EPS Next 2Y28.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.97%
Revenue Next 2Y3.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HLF Yearly Revenue VS EstimatesHLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
HLF Yearly EPS VS EstimatesHLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

  • HLF is valuated reasonably with a Price/Earnings ratio of 9.04.
  • Based on the Price/Earnings ratio, HLF is valued cheaper than 91.67% of the companies in the same industry.
  • HLF's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.98.
  • HLF is valuated cheaply with a Price/Forward Earnings ratio of 7.28.
  • 88.89% of the companies in the same industry are more expensive than HLF, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.01, HLF is valued rather cheaply.
Industry RankSector Rank
PE 9.04
Fwd PE 7.28
HLF Price Earnings VS Forward Price EarningsHLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLF indicates a rather cheap valuation: HLF is cheaper than 88.89% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.87
EV/EBITDA N/A
HLF Per share dataHLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • HLF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HLF's earnings are expected to grow with 28.70% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y28.7%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • HLF does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HERBALIFE LTD

NYSE:HLF (2/25/2026, 12:27:43 PM)

19.26

-0.34 (-1.73%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-18
Earnings (Next)04-28
Inst Owners101.76%
Inst Owner Change3.17%
Ins Owners1.97%
Ins Owner Change-0.99%
Market Cap1.99B
Revenue(TTM)5.04B
Net Income(TTM)228.30M
Analysts77.78
Price Target17.34 (-9.97%)
Short Float %8.88%
Short Ratio5.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.93%
Min EPS beat(2)4.47%
Max EPS beat(2)7.39%
EPS beat(4)4
Avg EPS beat(4)30.94%
Min EPS beat(4)4.47%
Max EPS beat(4)59.17%
EPS beat(8)8
Avg EPS beat(8)40.78%
EPS beat(12)9
Avg EPS beat(12)22.69%
EPS beat(16)13
Avg EPS beat(16)25.36%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)2.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)2.07%
Revenue beat(8)2
Avg Revenue beat(8)-0.99%
Revenue beat(12)6
Avg Revenue beat(12)-0.06%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)0%
PT rev (3m)55.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.8%
EPS NY rev (3m)0.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.04
Fwd PE 7.28
P/S 0.39
P/FCF 7.87
P/OCF 5.97
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.13
EY11.06%
EPS(NY)2.64
Fwd EY13.73%
FCF(TTM)2.45
FCFY12.71%
OCF(TTM)3.23
OCFY16.75%
SpS48.76
BVpS-4.99
TBVpS-9.01
PEG (NY)0.37
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.53%
GM 77.87%
FCFM 5.02%
ROA(3y)7.53%
ROA(5y)10.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)29.25%
ROCE(5y)32.45%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.15%
OM growth 5Y-3.06%
PM growth 3Y-9.79%
PM growth 5Y-7.59%
GM growth 3Y0.18%
GM growth 5Y-0.35%
F-Score6
Asset Turnover1.81
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.88
Debt/EBITDA N/A
Cap/Depr 66.34%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 110.78%
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.22
F-Score6
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)95.33%
Cap/Depr(5y)112.44%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.46%
Profit Quality(3y)110.5%
Profit Quality(5y)92.32%
High Growth Momentum
Growth
EPS 1Y (TTM)8.67%
EPS 3Y-14.35%
EPS 5Y-10.16%
EPS Q2Q%25%
EPS Next Y24.17%
EPS Next 2Y28.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-1.08%
Revenue growth 5Y-1.89%
Sales Q2Q%6.26%
Revenue Next Year2.97%
Revenue Next 2Y3.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-231.85%
EBIT growth 3Y-4.2%
EBIT growth 5Y-4.89%
EBIT Next Year36.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.77%
FCF growth 3Y8.85%
FCF growth 5Y-13.31%
OCF growth 1Y16.78%
OCF growth 3Y-1.85%
OCF growth 5Y-11.92%

HERBALIFE LTD / HLF FAQ

Can you provide the ChartMill fundamental rating for HERBALIFE LTD?

ChartMill assigns a fundamental rating of 4 / 10 to HLF.


What is the valuation status for HLF stock?

ChartMill assigns a valuation rating of 8 / 10 to HERBALIFE LTD (HLF). This can be considered as Undervalued.


What is the profitability of HLF stock?

HERBALIFE LTD (HLF) has a profitability rating of 4 / 10.


What are the PE and PB ratios of HERBALIFE LTD (HLF) stock?

The Price/Earnings (PE) ratio for HERBALIFE LTD (HLF) is 9.04 and the Price/Book (PB) ratio is -3.86.


What is the earnings growth outlook for HERBALIFE LTD?

The Earnings per Share (EPS) of HERBALIFE LTD (HLF) is expected to grow by 24.17% in the next year.